Microbiota is an essential element for mice to initiate a protective immunity againstVaccinia virus
Author(s) -
Maurício Lima,
Ana Cláudia S. P. Andrade,
Graziele Pereira Oliveira,
Rafael Calixto,
Danilo Bretas de Oliveira,
L. S. Souza,
Giliane S. Trindade,
Jacques R. Nicoli,
Erna Geessien Kroon,
Flaviano S. Martins,
Jônatas Santos Abrahão
Publication year - 2015
Publication title -
fems microbiology ecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.377
H-Index - 155
eISSN - 1574-6941
pISSN - 0168-6496
DOI - 10.1093/femsec/fiv147
Subject(s) - biology , vaccinia , immunity , virology , virus , microbiology and biotechnology , immune system , poxviridae , immunology , genetics , gene , recombinant dna
The gastrointestinal tract of vertebrates harbors one of the most complex ecosystems known in microbial ecology and this indigenous microbiota almost always has a profound influence on host-parasite relationships, which can enhance or reduce the pathology of the infection. In this context, the impact of the microbiota during the infection of several viral groups remains poorly studied, including the family Poxviridae. Vaccinia virus (VACV) is a member of this family and is the causative agent of bovine vaccinia, responsible for outbreaks that affect bovines and humans. To determine the influence of the microbiota in the development of the disease caused by VACV, a comparative study using a murine model was performed. Germ-free and conventional, 6- to 7-week-old Swiss NIH mice were infected by tail scarification and intranasally with VACV. Moreover, immunosuppression and microbiota reposition were performed, to establish the interactions among the host's immune system, microbiota and VACV. The data demonstrate that the microbiota is essential for the effective immune response of mice against VACV in intranasal inoculation and to control the virus at the primary site of infection. Furthermore, this study is the first to show that Swiss conventional mice are refractory to the intranasal infection of VACV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom